PREVENT DIABETES Act

U.S. Congress · HR1523 · In Committee

Progression

Timing in context

Primary sponsor's contributions received (same period)

Adjacency in time is shown for context; it is not evidence of cause. Funded ≠ false — see the methodology.

What the bill says

HR1523 · U.S. Congress · In Committee

Introduced 2025-02-24. Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

View on Congress.gov →

Summary (plain-language)

Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-based Strategies Act or the PREVENT DIABETES Act This bill allows health care entities to provide virtual services under the Medicare Diabetes Prevention Program for an additional three years. The Medicare Diabetes Prevention Program offers Medicare beneficiaries who are at risk of developing Type 2 diabetes specialized training and education regarding diet, exercise, and other behavioral changes. The Centers for Medicare & Medicaid Services issued temporary authorization for entities participating in the program to provide these services virtually until December 31, 2027. The bill extends the authorization for virtual services until December 31, 2030.

Sponsors

Text versions

  • Introduced in House — 2025-02-24 — XML

What analysts say

No nonpartisan analysis on file for this measure yet.

What politicians say

No linked claims or utterances yet — no one on record has cited this measure to justify a public argument.

Action History

DateAction
2025-02-24Introduced in House
2025-02-24Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Lobbying on this bill

Showing 5 of 5 bill mentions.

Honesty note: each filer below disclosed lobbying on this bill — that much the filing tells us. But the dollar figure is their total lobbying spend for the whole quarter across all their issues, not the amount spent on this bill, and the filing never says whether they supported or opposed it.

Registrant (lobbying firm)ClientPeriodReported quarterly amountExtraction
ATA ACTION ATA ACTION Q2 2026 $30,000 Explicit
ADVANCED POLICY CONSULTING, LLC ATA ACTION Q2 2026 $20,000 Explicit
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) Q1 2026 $5,320,000 Explicit
ADVANCED POLICY CONSULTING, LLC ATA ACTION Q1 2026 $20,000 Explicit
ATA ACTION ATA ACTION Q1 2026 $30,000 Explicit

Source: Senate LDA filings.